Koob George F
National Institute on Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Room 2001, Suite 2000, Rockville, MD, 20852, USA.
Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3.
Addiction is defined as a chronically relapsing disorder characterized by compulsive drug seeking that is hypothesized to derive from multiple sources of motivational dysregulation.
Dr. Athina Markou made seminal contributions to our understanding of the neurobiology of addiction with her studies on the dysregulation of reward function using animal models with construct validity. Repeated overstimulation of the reward systems with drugs of abuse decreases reward function, characterized by brain stimulation reward and presumbably reflecting dysphoria-like states. The construct of negative reinforcement, defined as drug taking that alleviates a negative emotional state that is created by drug abstinence, is particularly relevant as a driving force in both the withdrawal/negative affect and preoccupation/anticipation stages of the addiction cycle.
The negative emotional state that drives such negative reinforcement is hypothesized to derive from the dysregulation of key neurochemical circuits that drive incentive-salience/reward systems (dopamine, opioid peptides) in the ventral striatum and from the recruitment of brain stress systems (corticotropin-releasing factor, dynorphin) within the extended amygdala. As drug taking becomes compulsive-like, the factors that motivate behavior are hypothesized to shift to drug-seeking behavior that is driven not only by positive reinforcement but also by negative reinforcement. This shift in motivation is hypothesized to reflect the allostatic misregulation of hedonic tone such that drug taking makes the hedonic negative emotional state worse during the process of seeking temporary relief with compulsive drug taking.
成瘾被定义为一种慢性复发性疾病,其特征是强迫性觅药行为,据推测这源于多种动机调节障碍。
阿西娜·马尔库博士通过使用具有结构效度的动物模型对奖赏功能失调进行研究,为我们理解成瘾的神经生物学做出了开创性贡献。反复用滥用药物过度刺激奖赏系统会降低奖赏功能,其特征为脑刺激奖赏,可能反映出类似烦躁不安的状态。负性强化的概念,即通过服药来缓解因药物戒断产生的负性情绪状态,作为成瘾周期中戒断/负性情绪和专注/期待阶段的驱动力尤为重要。
据推测,驱动这种负性强化的负性情绪状态源于腹侧纹状体中驱动动机显著性/奖赏系统(多巴胺、阿片肽)的关键神经化学回路失调,以及杏仁核扩展区域内脑应激系统(促肾上腺皮质激素释放因子、强啡肽)的激活。随着服药行为变得类似强迫行为,据推测驱动行为的因素会转变为不仅由正性强化而且由负性强化驱动的觅药行为。这种动机转变据推测反映了享乐基调的非稳态失调,以至于在强迫性服药寻求暂时缓解的过程中,服药会使享乐性负性情绪状态恶化。